BioTech – Founder’s Digest

immunitoAI lands $6.1 Mn to develop antibody treatment

26

Nov

2025

BioTech Health Tech

immunitoAI’s $6.1M Series A Signals Indian Deep Tech Maturation—Valuation Arbitrage Closes by 2026

immunitoAI’s $6.1M raise marks the shift from Indian “bio-services” to “bio-IP”—early-stage valuation gaps vs. US peers compress…